Vytorin-cancer link can't be ruled out

[0:14]..." overweight among children and adolescents. And it certainly were ready seeing some health problems when when but people are our at younger ages. But we wanted to ask the question on the population level in the entire US population. What what can we expect for the future as a consequence of these high rates of obesity and overweight and today's teenagers. We use that computer model that actually -- protect. Population rates of heart disease in the entire US adult population -- a model that's been around for awhile has been went well validated. And uses national data on the rate of obesity on hospital patient raid the US census projections for the population US death rate. And using this computer simulation. We asked how much more heart disease could today's teenagers six -- when they're 35 to 50 years of age. And what we've found was that the prevalence of heart disease that the amount that the number of cases of heart disease. Would go up by as much as 16% to and that the rate of heart disease death. We go up by as much as 19%. And but to some extent that the results are not surprising we know that it is not. That's an excessive weight gain it in in childhood and adolescence is not healthy I think we were really struck by the magnitude. -- rise in heart disease that we could anticipate in the future. Remember that where we error. We're looking at a young adult population 35 to 50 years old these are people who don't ordinarily we don't ordinarily think about getting heart disease we don't ordinarily think about having heart attacks being non. Chronic medications or even of dying in that age range and what we're what we're seeing -- what we're projecting is that well actually the shift in. In how heart disease develops in this country says that. That the younger adult population will actually be at risk for instance -- "...

[2:28]..." So we're talking about our cardiovascular disease and premature death into an -- and the number of people. "...

[3:40]..." patients but for a drug companies are thinking about. Cholesterol lowering drugs high blood pressure medication diabetes this drugs and so forth. "...

[0:00]..." Like that the drug load and it has -- side effect of causing a very hand foot 400 it's Cobb. In which you began in grade won with just some irritation. And ration "...

[0:32]..." end the drugmaker that. It really doesn't help so much with this side effect. "...

[2:19]..." your dose of reducing it doesn't that he did not event include anti cancer but I put this time. I take half an hour later my feet felt cool within two days the chance that sentiment. "...

[0:08]..." medication on children connect congressional investigators say they took money from those drug companies they never disclosed it -- obviously joining us this morning on this and and I guess that's a problem for some obviously not so obvious reasons rival the use of these drugs is already controversial on children and now this is really just adding to it according to the New York Times. Three Harvard researchers are accused of taking over one million dollars each. From pharmaceutical companies and not disclosing those payments as required by the federal government. One of the doctors is Joseph Biederman considered a world renowned children's psychiatrist. His work led to a huge increase in the diagnosis of pediatric bipolar disorder and a rise in the use of anti psychotic drugs in children. Congressional investigators say he took over one and a half million dollars from drug companies over the past. Seven years to other doctors at harbor are implicated -- well. They're not as high profile -- as doctor Biederman now doctor Biederman says he is only interested in the advancement of treatments through object of study. Can and Paula this could hurt other research in Boston since the federal government. Relies on universities to monitor any sort of outside money. The NIH made then as a penalty restrict grants or suspend them altogether that's a lot on the line there it would seem conflict "...